A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 57,841 shares of RGNX stock, worth $385,799. This represents 0.12% of its overall portfolio holdings.

Number of Shares
57,841
Holding current value
$385,799
% of portfolio
0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$7.23 - $11.56 $418,190 - $668,641
57,841 New
57,841 $447 Million
Q1 2024

May 15, 2024

BUY
$12.17 - $24.61 $11,293 - $22,838
928 New
928 $19.6 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $288M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.